New electric pulse method tested for stubborn heart rhythm disorder
NCT ID NCT06134752
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of ablation—pulse field and radiofrequency—for treating persistent atrial fibrillation, a common heart rhythm problem. Fifty participants will receive one of the two procedures to isolate faulty electrical areas in the heart. The goal is to see which method creates longer-lasting isolation and better controls abnormal heart rhythms over a year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pulse field ablation and radiofrequency ablation
What this could lead to
If pulse field ablation proves more durable, it could offer a more effective, safer option for controlling persistent atrial fibrillation.
What could go wrong
This is a small, early-stage comparison (50 participants) with no phase designation, so results may not be conclusive or widely applicable. Both procedures carry risks like bleeding or heart tissue damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cardiovascular Surgery Department, University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia